We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
This case reports male breast cancer linked to BRCA2 mutation after prolonged 5α-reductase inhibitor use, highlighting potential risks.
5α還元酵素阻害剤(5 alpha-reductase inhibitor,以下5-ARI)長期内服歴のあるBRCA2陽性男性乳癌を経験したので,文献的考察を加えて報告する.
No takes yet. Share an insight, caveat, or question.
Nomoto et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: